The Archive

Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan, as reported by Reuters. The funding is part of a $1.8 billion initiative to build AI datasets that could allow researchers to "ask, predict, and answer biological questions digitally," helping find new ways to prevent and manage diseases. Founded in 2016, Biohub aims to combat diseases through the creation of a "virtual cell" that researchers can use to carry out simulations....

Google is making some significant AI leadership changes, including a major shift for Google DeepMind leader Demis Hassabis. Hassabis will become the chair of Google DeepMind and the chief scientist at Alphabet, CEO Sundar Pichai announced on Wednesday. Hassabis will continue to lead Alphabet's Isomorphic Labs, which aims to use AI to develop drugs. Koray Kavukcuoglu, formerly DeepMind's CTO, is stepping up to become Google's SVP of DeepMind and will report to Pichai. Kavukcuoglu will remain Google's chief AI architect as well. "​​As you've heard me say many times, I've always believed the No....

Google DeepMind and Isomorphic Labs outline joint approach to applying AI models for biological resilience research.

Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that the bigger obstacle is access, and that Claude solves it.

Isomorphic Labs closes $2.1B Series B led by Temasek and Loweringthe Bar to scale AI for drug discovery and protein folding.